Free Trial

Park Dental Partners (PARK) Competitors

$17.98 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$17.98 +0.00 (+0.03%)
As of 06/12/2026 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PARK vs. AUNA, SBC, LFMD, BDSX, and XGN

Should you buy Park Dental Partners stock or one of its competitors? MarketBeat compares Park Dental Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Park Dental Partners include Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), Biodesix (BDSX), and Exagen (XGN). These companies are all part of the "healthcare" industry.

How does Park Dental Partners compare to Auna?

Park Dental Partners (NASDAQ:PARK) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

In the previous week, Park Dental Partners had 2 more articles in the media than Auna. MarketBeat recorded 2 mentions for Park Dental Partners and 0 mentions for Auna. Park Dental Partners' average media sentiment score of 0.63 beat Auna's score of 0.00 indicating that Park Dental Partners is being referred to more favorably in the media.

Company Overall Sentiment
Park Dental Partners Positive
Auna Neutral

Auna has higher revenue and earnings than Park Dental Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.33N/AN/AN/A
Auna$1.23B0.30$27.39M$0.2618.98

Park Dental Partners presently has a consensus price target of $21.75, suggesting a potential upside of 20.97%. Auna has a consensus price target of $6.97, suggesting a potential upside of 41.17%. Given Auna's higher possible upside, analysts clearly believe Auna is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
Auna
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.40

Auna has a net margin of 1.53% compared to Park Dental Partners' net margin of 0.00%. Auna's return on equity of 16.25% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Auna 1.53%16.25%4.03%

Summary

Auna beats Park Dental Partners on 6 of the 11 factors compared between the two stocks.

How does Park Dental Partners compare to SBC Medical Group?

SBC Medical Group (NASDAQ:SBC) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

SBC Medical Group has a net margin of 24.09% compared to Park Dental Partners' net margin of 0.00%. SBC Medical Group's return on equity of 15.90% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group24.09% 15.90% 11.61%
Park Dental Partners N/A N/A N/A

SBC Medical Group has higher earnings, but lower revenue than Park Dental Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M1.70$50.99M$0.397.36
Park Dental Partners$244.49M0.33N/AN/AN/A

60.8% of SBC Medical Group shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 10.6% of Park Dental Partners shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

SBC Medical Group currently has a consensus price target of $8.50, suggesting a potential upside of 196.17%. Park Dental Partners has a consensus price target of $21.75, suggesting a potential upside of 20.97%. Given SBC Medical Group's higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75

In the previous week, SBC Medical Group and SBC Medical Group both had 2 articles in the media. SBC Medical Group's average media sentiment score of 1.28 beat Park Dental Partners' score of 0.63 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Park Dental Partners
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

SBC Medical Group beats Park Dental Partners on 9 of the 12 factors compared between the two stocks.

How does Park Dental Partners compare to LifeMD?

LifeMD (NASDAQ:LFMD) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

In the previous week, Park Dental Partners had 1 more articles in the media than LifeMD. MarketBeat recorded 2 mentions for Park Dental Partners and 1 mentions for LifeMD. LifeMD's average media sentiment score of 1.87 beat Park Dental Partners' score of 0.63 indicating that LifeMD is being referred to more favorably in the media.

Company Overall Sentiment
LifeMD Very Positive
Park Dental Partners Positive

35.5% of LifeMD shares are held by institutional investors. 17.2% of LifeMD shares are held by company insiders. Comparatively, 10.6% of Park Dental Partners shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

LifeMD has a net margin of 2.37% compared to Park Dental Partners' net margin of 0.00%. Park Dental Partners' return on equity of 0.00% beat LifeMD's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeMD2.37% -150.88% -22.59%
Park Dental Partners N/A N/A N/A

LifeMD has higher earnings, but lower revenue than Park Dental Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$194.05M1.17$14.35M$0.0594.00
Park Dental Partners$244.49M0.33N/AN/AN/A

LifeMD presently has a consensus target price of $9.14, suggesting a potential upside of 94.53%. Park Dental Partners has a consensus target price of $21.75, suggesting a potential upside of 20.97%. Given LifeMD's higher possible upside, equities research analysts plainly believe LifeMD is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.70
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75

Summary

LifeMD beats Park Dental Partners on 7 of the 13 factors compared between the two stocks.

How does Park Dental Partners compare to Biodesix?

Park Dental Partners (NASDAQ:PARK) and Biodesix (NASDAQ:BDSX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

Park Dental Partners has higher revenue and earnings than Biodesix.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.33N/AN/AN/A
Biodesix$88.50M1.76-$35.26M-$4.06N/A

Park Dental Partners has a net margin of 0.00% compared to Biodesix's net margin of -33.26%. Park Dental Partners' return on equity of 0.00% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Biodesix -33.26%-2,101.40%-35.65%

21.0% of Biodesix shares are owned by institutional investors. 10.6% of Park Dental Partners shares are owned by insiders. Comparatively, 23.2% of Biodesix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Park Dental Partners had 1 more articles in the media than Biodesix. MarketBeat recorded 2 mentions for Park Dental Partners and 1 mentions for Biodesix. Biodesix's average media sentiment score of 1.44 beat Park Dental Partners' score of 0.63 indicating that Biodesix is being referred to more favorably in the news media.

Company Overall Sentiment
Park Dental Partners Positive
Biodesix Positive

Park Dental Partners presently has a consensus price target of $21.75, indicating a potential upside of 20.97%. Biodesix has a consensus price target of $24.00, indicating a potential upside of 59.36%. Given Biodesix's higher possible upside, analysts clearly believe Biodesix is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
Biodesix
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Park Dental Partners beats Biodesix on 7 of the 13 factors compared between the two stocks.

How does Park Dental Partners compare to Exagen?

Park Dental Partners (NASDAQ:PARK) and Exagen (NASDAQ:XGN) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

Park Dental Partners has higher revenue and earnings than Exagen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.33N/AN/AN/A
Exagen$66.57M1.69-$19.95M-$0.89N/A

In the previous week, Exagen had 2 more articles in the media than Park Dental Partners. MarketBeat recorded 4 mentions for Exagen and 2 mentions for Park Dental Partners. Park Dental Partners' average media sentiment score of 0.63 beat Exagen's score of 0.61 indicating that Park Dental Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Park Dental Partners
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Exagen
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Park Dental Partners currently has a consensus price target of $21.75, indicating a potential upside of 20.97%. Exagen has a consensus price target of $9.25, indicating a potential upside of 98.07%. Given Exagen's stronger consensus rating and higher possible upside, analysts plainly believe Exagen is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
Exagen
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.78

75.3% of Exagen shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by insiders. Comparatively, 10.4% of Exagen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Park Dental Partners has a net margin of 0.00% compared to Exagen's net margin of -29.49%. Park Dental Partners' return on equity of 0.00% beat Exagen's return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Exagen -29.49%-94.37%-28.96%

Summary

Park Dental Partners beats Exagen on 7 of the 13 factors compared between the two stocks.

Get Park Dental Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for PARK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PARK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PARK vs. The Competition

MetricPark Dental PartnersServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$81.27M$1.84B$962.91M$12.05B
Dividend YieldN/AN/A4.70%5.66%
P/E RatioN/A16.8011.0324.42
Price / Sales0.335.8642.48118.72
Price / CashN/A161.8455.6237.92
Price / BookN/A37.4411.346.82
Net IncomeN/A-$33.67M-$12.34M$337.56M
7 Day Performance0.06%4.66%6.74%1.16%
1 Month Performance-0.83%6.43%2.59%3.16%
1 Year PerformanceN/AN/A97.26%30.60%

Park Dental Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PARK
Park Dental Partners
3.8063 of 5 stars
$17.98
flat
$21.75
+21.0%
N/A$81.27M$244.49MN/A1,208
AUNA
Auna
4.802 of 5 stars
$4.52
+2.5%
$6.97
+54.1%
-21.9%$326.40M$1.23B17.3915,254
SBC
SBC Medical Group
3.7878 of 5 stars
$2.96
-1.7%
$8.50
+187.2%
-35.2%$308.76M$173.61M7.59N/A
LFMD
LifeMD
3.4437 of 5 stars
$5.02
+2.7%
$9.14
+82.1%
-62.3%$236.49M$194.05M100.42230
BDSX
Biodesix
3.6905 of 5 stars
$14.95
-3.3%
$22.00
+47.2%
+162.6%$160.10M$88.50MN/A220

Related Companies and Tools


This page (NASDAQ:PARK) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners